About Instituto de Cardiologia do Rio Grande do Sul
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
Instituto de Cardiologia do Rio Grande do Sul
19
Boehringer Ingelheim
5
Cardiovascular Research Center, Brazil
2
Eidos Therapeutics, a BridgeBio company
2
Hospital do Coracao
2
Scitech Produtos Medicos Ltda
2
Amgen
1
Arbor Pharmaceuticals, Inc.
1
Bristol-Myers Squibb
1
Daiichi Sankyo, Inc.
1
Federal University of Rio Grande do Sul
1
Clinical Trials at Instituto de Cardiologia do Rio Grande do Sul
During the past decade, Instituto de Cardiologia do Rio Grande do Sul conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 7 clinical trials were completed, i.e. on
average, 38.9% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 4 clinical trials were completed. i.e. 57.1%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Instituto de Cardiologia do Rio Grande do Sul" #1 sponsor was "Instituto de Cardiologia do Rio Grande do Sul" with 19 trials, followed by "Boehringer Ingelheim" with 5 trials
sponsored, "Cardiovascular Research Center, Brazil" with 2 trials sponsored, "Eidos Therapeutics, a BridgeBio company" with 2 trials sponsored and "Hospital do Coracao"
with 2 trials sponsored. Other sponsors include 8 different institutions and
companies that sponsored additional 17 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Instituto de Cardiologia do Rio Grande do Sul"
#1 collaborator was "Conselho Nacional de Desenvolvimento Científico e Tecnológico" with 4 trials as a collaborator, "Eli Lilly and Company" with 4 trials as a collaborator, "Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul, Brazil" with 3 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "CNPq Universal" with 1 trials as a collaborator. Other collaborators include 10 different institutions and companies that were
collaborators in the rest 20 trials.
Clinical Trials Conditions at Instituto de Cardiologia do Rio Grande do Sul
According to Clinical.Site data, the most researched conditions in "Instituto de Cardiologia do Rio Grande do Sul" are
"Heart Failure" (5 trials), "Hypertension" (5 trials), "Coronary Artery Disease" (3 trials), "Cardiovascular Diseases" (2 trials) and "Dilated Cardiomyopathy" (2 trials). Many other conditions were trialed in "Instituto de Cardiologia do Rio Grande do Sul" in a lesser frequency.
Clinical Trials Intervention Types at Instituto de Cardiologia do Rio Grande do Sul
Most popular intervention types in "Instituto de Cardiologia do Rio Grande do Sul" are "Drug" (18 trials), "Other" (10 trials), "Dietary Supplement" (5 trials), "Procedure" (4 trials) and "Device" (3 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "Empagliflozin" (3 trials), "Conventional treatment and follow up" (2 trials), "Methotrexate" (2 trials) and "Multidisciplinary assistance" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Instituto de Cardiologia do Rio Grande do Sul
The vast majority of trials in "Instituto de Cardiologia do Rio Grande do Sul" are
40 trials for "All" genders and 3 trials for "Female" genders.
Clinical Trials Status at Instituto de Cardiologia do Rio Grande do Sul
Currently, there are 7 active trials in "Instituto de Cardiologia do Rio Grande do Sul".
2 are not yet recruiting,
2 are recruiting,
2 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 27 completed trials in Instituto de Cardiologia do Rio Grande do Sul,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Instituto de Cardiologia do Rio Grande do Sul, 2 "Phase 1"
clinical trials were conducted, 8 "Phase 2" clinical
trials and 14 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 6 trials, and there were
also 15 trials that are defined as “Not Applicable".